The Greens say that the Government must continue to expand and diversify Australia’s vaccine portfolio immediately in light of the varying rates of effectiveness of vaccines against new strains. 
 
“We cannot rely on AstraZeneca as our only contingency plan - we need to have a diverse portfolio to rapidly pivot to deal with new strains, including securing deals with Moderna and more Pfizer doses", Greens spokesperson on Health Senator Rachel Siewert said. 
 

 
The Greens recognise the potential role of e-cigarettes in tobacco harm reduction but support a precautionary approach in the regulation of e-cigarettes.

The Greens support the recommendations of the majority Select Committee on Tobacco Harm Reduction report and have made some additional comments.

The Australian Greens strongly support the call from over 30 health groups' for the Government to address climate change in the National Preventive Health Strategy.

"The Strategy's Consultation paper does not include climate change in its six focus areas, nor even mention climate change.

This is simply not good enough," said Senator Rachel Siewert, Australian Greens spokesperson on Health.

The Greens are pleased that the Government has finally announced that Australia has joined the COVAX facility. 

Australia’s participation in COVAX is critical to ensuring developing countries, especially our neighbours in the Pacific, have access to a Covid-19 vaccine as soon as it becomes available.

Australia has a responsibility to be part of the solution to vaccine nationalism. 

The Government must continue to commit funding to COVAX to actively support smaller nations to access Covid-19 vaccines. 

 The Greens welcome the strategies proposed by the Grattan Institute Report Go For Zero and support the goal of zero transmission.
 

COVID-19 has the potential to cause severe harm to First Nations communities particularly in regional and remote areas, older Australians, disabled people and people with mental health issues.

“Preventing and slowing the spread of the virus to First Nations communities must be a priority given that First Nations communities already suffer higher rates of chronic and respiratory illness than the general population,” Senator Rachel Siewert, spokesperson on First Nations issues said.

The Senate Community Affairs References committee has tabled its report on the risks and impacts of transvaginal mesh implants, which have been carried out since the late 1990’s to treat stress urinary incontinence and pelvic organ prolapse in women.

“Many women who have had transvaginal mesh implants have had devastating complications resulting in ongoing emotional trauma, embarrassment, shame, depression, debilitating pain, recurring infection and a poor quality of life.